News and analysis on diagnostic technologies and applications.
The company is also working in parallel on an at-home test that would be over the counter and return results within an hour.
Released by the Pandemic Response Accountability Committee, the report looks at data on test volume, turnaround, cost, and usage at six federal agencies.
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.
The test has been authorized for use with individual respiratory specimens, as well as with pooled specimens containing up to five samples.
Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials.
